Home > Drug Search >
  • company_query: Bio-Ker
  •   > 
Drug Filter
Category:
chemistry (3) biology (32)
Status:
Approved (4) NDA Filing (1) BLA Filing (2) Phase Ⅲ (8) Phase Ⅱ (14) Phase Ⅰ (6)
Clinical Stage:
Pending (2) Active (26) Discontinued (3)
Bio-Type:
Gene therapy (1) Cell therapy (1) Vaccine (7) Recombinant enzyme (1) Recombinant cytokines (3) Whole antibody (6) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Acute myeloid Leukemia (AML) (1) Amyotrophic lateral sclerosis (ALS) (1) Breast cancer (3) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) Deep vein thrombosis (DVT) (1) Follicular lymphoma (1) HCV infection (1) Alcoholic hepatitis (1) Hepatocellular carcinoma (HCC) (1) Inflammatory bowel disease (1) Influenza virus infection (1) Pseudomonal infection (1) Melanoma (2) Multiple myeloma (MM) (2) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Pancreatic cancer (1) Pneumonia (1) Prostate cancer (2) Pulmonary embolism (1) Rheumatoid arthritis (RA) (1) Solid tumours (3) Tuberculosis (1) Type 2 diabetes (2) Colorectal cancer (1) Paroxysmal Nocturnal Hemoglobinuria (PNH) (1) Autistic disorder (1) Malaria (1) Neutropenia (3) Renal carcinoma (1) Autoimmune diseases (1) Staphylococcal infection (1) Glioma (2) Clostridial infection (1) Plaque psoriasis (3) Diffuse large B cell lymphoma (1) Skin disorders (1) Human papillomavirus infections (HPV) (1) Blood coagulation disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top